How a Japanese drugmaker got the ‘clean win’ over Alzheimer’s
Three decades after the presumed cause of Alzheimer’s disease was identified, a Japanese company little known outside of the pharmaceutical industry has become the first drugmaker to prove the debilitating condition can be a Tokyo-based pharmaceutical company with…
Read More